MAIT cell activation augments adenovirus vector vaccine immunogenicity. (2021)

First Author: Provine NM
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.aax8819

PubMed Identifier: 33510029

Publication URI: http://europepmc.org/abstract/MED/33510029

Type: Journal Article/Review

Volume: 371

Parent Publication: Science (New York, N.Y.)

Issue: 6528

ISSN: 0036-8075